Skip to content
PubMed This is a summary of 98 peer-reviewed journal articles Updated
Neurology

Post-Infectious Neuralgia: A Patient Guide

At a Glance

Post-infectious neuralgia is nerve pain that remains after an infection because inflammation or nerve injury can make the nervous system overreact. Treatment usually targets pain signals and daily function with medicines, topical treatments, or procedures.

Post-infectious neuralgia is a descriptive term for neuropathic pain—nerve pain—that occurs after or in association with an infection. It is a complex condition that encompasses several specific diagnoses, rather than a single uniform disease. The most common and well-established is postherpetic neuralgia (PHN) (following shingles), though neuropathic pain is also recognized in people recovering from Lyme disease, HIV, and increasingly, COVID-19 [1][2]. For many patients, the most difficult aspect of this condition is the contradiction between a medical report showing no active infection and the very real, often debilitating sensations of burning, stabbing, or extreme sensitivity that remain [3].

The transition from an infection to chronic neuralgia happens because the initial illness has physically or chemically altered the way your nervous system functions. In a healthy state, your nerves act as balanced messengers; however, the inflammation or direct injury caused by a pathogen can leave these nerves highly sensitized. Researchers use proposed models like peripheral and central sensitization to describe how your nerves may fire spontaneously and your brain may become hypersensitive to even the mildest signals [4][5]. Essentially, the alarm system gets stuck in the “on” position, misinterpreting normal touch or temperature as intense pain [6]. While these models are not inevitable or fully established states, they help explain the persistence of pain.

Because the acute infection is typically no longer driving the pain in conditions like established PHN, standard tools for treating illness—such as antibiotics or antivirals—are generally not effective for the neuralgia itself. However, any new rash, fever, or atypical progression requires reassessment to rule out an active infection. Management usually focuses on calming the overactive nervous system through medications that stabilize electrical signals, such as gabapentinoids, SNRIs, or tricyclic antidepressants, and targeted topical treatments like lidocaine patches [7][8]. For cases where medications aren’t enough, advanced interventional procedures like nerve blocks or neuromodulation are sometimes considered [9][10].

The journey through post-infectious neuralgia is often one of gradual recovery and adaptation. While the pain can be unpredictable and deeply frustrating, understanding that it is a biological consequence of nerve injury is an important step in reclaiming your quality of life. The focus of your care team will be on improving your daily function and sleep, with the goal of turning down the “volume” of the pain [11][3].

Common questions in this guide

What is post-infectious neuralgia?
Post-infectious neuralgia is nerve pain that occurs after or in association with an infection. It can occur in people recovering from infections such as shingles, Lyme disease, HIV, or COVID-19; postherpetic neuralgia after shingles is the best-established example.
Why can nerve pain continue after an infection has cleared?
Inflammation or direct injury from an infection can change how nerves send signals and how the brain interprets them. As a result, nerves may fire too easily, so ordinary touch or temperature can feel painful even when no active infection is found.
Do antibiotics or antivirals treat post-infectious neuralgia?
Usually not when the acute infection has ended and established neuralgia is causing the pain. New fever, a rash, or an unusual change in symptoms should be medically reassessed because it may signal an active infection or another problem.
What treatments may help post-infectious neuralgia?
Treatment may include gabapentinoids, SNRIs, tricyclic antidepressants, or topical lidocaine patches to reduce overactive pain signals. If medicines do not provide enough relief, a clinician may consider nerve blocks or neuromodulation.
What does allodynia feel like?
Allodynia means that a normally harmless sensation, such as clothing touching the skin or a light breeze, causes significant pain or distress. Telling your clinician about these triggers can help describe the pattern of your nerve pain.
What should be the goal of treatment for persistent nerve pain?
Goals are often better sleep, improved mobility and daily function, and a meaningful reduction in pain rather than an immediate complete cure. You and your care team can decide which changes matter most and track progress over time.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my history, which specific post-infectious condition (like PHN or post-Lyme pain) am I experiencing?
  2. 2.Since my acute infection has passed, what are the proposed biological mechanisms for why my pain persists?
  3. 3.What are our primary goals for my quality of life—better sleep, increased mobility, or a specific percentage of pain reduction?
  4. 4.Which type of specialist, such as a neurologist or a pain management physician, should lead my care team?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    The IASP classification of chronic pain for ICD-11: chronic neuropathic pain.

    Scholz J, Finnerup NB, Attal N, et al.

    Pain 2019; (160(1)):53-59 doi:10.1097/j.pain.0000000000001365.

    PMID: 30586071
  2. 2

    Herpes Zoster and Postherpetic Neuralgia: Prevention and Management.

    Saguil A, Kane S, Mercado M, Lauters R

    American family physician 2017; (96(10)):656-663.

    PMID: 29431387
  3. 3

    Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology.

    Mallick-Searle T, Snodgrass B, Brant JM

    Journal of multidisciplinary healthcare 2016; (9()):447-454 doi:10.2147/JMDH.S106340.

    PMID: 27703368
  4. 4

    Rethinking the causes of pain in herpes zoster and postherpetic neuralgia: the ectopic pacemaker hypothesis.

    Devor M

    Pain reports 2018; (3(6)):e702 doi:10.1097/PR9.0000000000000702.

    PMID: 30706041
  5. 5

    Local Brain Activity Differences Between Herpes Zoster and Postherpetic Neuralgia Patients: A Resting-State Functional MRI Study.

    Cao S, Li Y, Deng W, et al.

    Pain physician 2017; (20(5)):E687-E699.

    PMID: 28727713
  6. 6

    Somatosensory profiles in acute herpes zoster and predictors of postherpetic neuralgia.

    Kramer S, Baeumler P, Geber C, et al.

    Pain 2019; (160(4)):882-894 doi:10.1097/j.pain.0000000000001467.

    PMID: 30585985
  7. 7

    Gabapentin for chronic neuropathic pain in adults.

    Wiffen PJ, Derry S, Bell RF, et al.

    The Cochrane database of systematic reviews 2017; (6()):CD007938 doi:10.1002/14651858.CD007938.pub4.

    PMID: 28597471
  8. 8

    Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives.

    Tang J, Zhang Y, Liu C, et al.

    Current pain and headache reports 2023; (27(9)):307-319 doi:10.1007/s11916-023-01146-x.

    PMID: 37493871
  9. 9

    From Short-Term Relief to Long-Term Management: A Meta-Analysis of Temporary Spinal Cord Stimulation and Pulsed Radiofrequency in Postherpetic Neuralgia.

    Abbas A, Sabet H, El-Moslemani M, et al.

    Neuromodulation : journal of the International Neuromodulation Society 2025; (28(6)):923-936 doi:10.1016/j.neurom.2025.03.076.

    PMID: 40278804
  10. 10

    Spinal Cord Stimulation and DREZ Lesioning for Refractory Postherpetic Neuralgia: An Exploratory Case Series.

    Jin W, Yang D, Li J, et al.

    Journal of pain research 2026; (19()):583921 doi:10.2147/JPR.S583921.

    PMID: 42046795
  11. 11

    8. Herpes zoster and post herpetic neuralgia.

    Adriaansen EJM, Jacobs JG, Vernooij LM, et al.

    Pain practice : the official journal of World Institute of Pain 2024; doi:10.1111/papr.13423.

    PMID: 39364882

This page is for informational purposes only and does not constitute medical advice. A neurologist, pain specialist, or other healthcare professional should evaluate your symptoms, especially new weakness, fever, or a rash.

Get notified when new evidence is published on post-infectious neuralgia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.